CMS Seeks Input on Pharmacy Benefit Manager Compensation and Data Reporting
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
CMS is asking for technical input on how pharmacy benefit managers and their affiliates are paid and what data they should report under upcoming Medicare Part D rules. The request focuses on new requirements taking effect in 2028, including limits on PBM compensation tied to covered Part D drugs and expanded reporting obligations. PBMs, Medicare Part D plan sponsors, pharmacies, drug manufacturers, insurers, and compliance teams should review the request and consider submitting comments by July 20, 2026. The information collected will shape future rules, so affected businesses have a chance to influence how compensation limits and reporting duties are designed.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- CMS is collecting technical input on PBM services, business practices, compensation, and data reporting.
- The request focuses on upcoming 2028 restrictions on compensation PBMs and affiliates may receive for services tied to covered Medicare Part D drugs.
- Comments are due by 5 p.m. on July 20, 2026, through regulations.gov, mail, or overnight delivery.